홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → HCID 178419433, 화합물

HRID 416837
인쇄

반응식

HRID 416837 반응식
BrC1C(N2CCN(CC3C=NC=CC=3)CC2)=C2N=C(C3C=CC(CN)=CC=3)NC2=NC=1.[Br:32][C:33]1[C:34]([N:61]2[CH2:66][CH2:65][N:64]([CH2:67][C:68]3[CH:69]=[N:70][CH:71]=[CH:72][CH:73]=3)[CH2:63][CH2:62]2)=[C:35]2[N:41]=[C:40]([C:42]3[CH:47]=[CH:46][C:45]([N:48]4[CH2:53][CH2:52][N:51](C(OC(C)(C)C)=O)[CH2:50][CH2:49]4)=[CH:44][CH:43]=3)[NH:39][C:36]2=[N:37][CH:38]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl>[Br:32][C:33]1[C:34]([N:61]2[CH2:62][CH2:63][N:64]([CH2:67][C:68]3[CH:69]=[N:70][CH:71]=[CH:72][CH:73]=3)[CH2:65][CH2:66]2)=[C:35]2[N:41]=[C:40]([C:42]3[CH:43]=[CH:44][C:45]([N:48]4[CH2:53][CH2:52][NH:51][CH2:50][CH2:49]4)=[CH:46][CH:47]=3)[NH:39][C:36]2=[N:37][CH:38]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 6422Trifluoroacetic acidHCID 178452226HCID 178452226, 화합물HCID 178509626HCID 178509626, 화합물

생성물 1

HCID 178419433HCID 178419433, 화합물수율 75%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

This was prepared using the same procedure as for (4-(6-bromo-7-(4-(pyridin-3-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridin-2-yl)phenyl)methanamine, but here using tert-butyl 4-(4-(6-bromo-7-(4-(pyridin-3-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridin-2-yl)phenyl)piperazine-1-carboxylate (16 mg, 0.025 mmol), TFA (0.25 mL) and CH2Cl2 (1 mL). The same purification procedure gave the desired product (10 mg, 75%) as a pale yellow solid; δH (500 MHz, DMSO-d6) 2.50 (hidden by DMSO peak, 2H, piperazine NCH2), 2.62 (s, br, 4H, piperazine N(CH2)2), 3.00 (s, br, 2H, piperazine NCH2), 3.30 (hidden by DMSO peak, 4H, piperazine N(CH2)2), 3.61 (s, 2H, NCH2), 3.64 (s, br, 4H, piperazine N(CH2)2), 7.06 (d, J=8.9 Hz, 2H, phenyl H-3 & H-5), 7.39 (dd, J=7.7, 4.8 Hz, 1H, pyridine H-5), 7.78 (d, br, J=7.7 Hz, 1H, pyridine H-4), 8.03 (d, J=8.9 Hz, 2H, phenyl H-2 & H-6), 8.17 (s, 1H, imidazo[4,5-b]pyridine H-5), 8.49 (dd, J=4.7, 1.4 Hz, 1H, pyridine H-6), 8.56 (s, br, 1H, pyridine H-2), 13.23 (s, br, 1H, imidazo[4,5-b]pyridine NH);

후처리

  1. customThis was prepared
  2. customThe same purification procedure

출처 및 근거

ORD 기록
ord-28a1dbd183114c64b77079afbdc128fe
출처 데이터셋
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08088761B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트